Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity
- 6 November 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Cell
- Vol. 80 (4), 592-606.e8
- https://doi.org/10.1016/j.molcel.2020.10.015
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2017M3A9G7073086, NRF-2018R1A2A1A05077703, NRF-2020R1A5A2017323)
- University of Kansas
- Ministry of Education (HI15C0001, HI16C1501)
- Ministry of Science, ICT and Future Planning (2017R1A6A3A04010231)
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
This publication has 62 references indexed in Scilit:
- Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitorsBiochemical and Biophysical Research Communications, 2013
- Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase InhibitorsJournal of Medicinal Chemistry, 2012
- The ConsensusPathDB interaction database: 2013 updateNucleic Acids Research, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemiaMolecular BioSystems, 2011
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Molecular Mechanisms and Clinical Implications of Reversible ProteinS-GlutathionylationAntioxidants and Redox Signaling, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994